A cancer-prone case with a background of methylation of p16 tumor suppressor gene

Clinical Cancer Research

Volumn 9, Issue 3, 2003, Pages 1053-1056

  Hibi, Kenji ^a   Koike, Masahiko ^a   Nakayama, Hiroshi ^a   Fujitake, Shinichi ^a   Kasai, Yasushi ^a   Ito, Katsuki ^a   Akiyama, Seiji ^a   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P16;

ARTICLE; BLOOD CELL; CANCER SUSCEPTIBILITY; COLON; COLON MUCOSA; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECTUM; TISSUE SECTION; TUMOR CELL; TUMOR SUPPRESSOR GENE;

COLORECTAL NEOPLASMS; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENES, P16; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; NEOPLASM METASTASIS; NEOPLASMS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; SULFITES;

EID: 0037339860     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bos, J. L., Fearon, E. R., Hamilton, S. R., Vries, M. V., Boom, J. H., Eb, A. J., and Vogelstein, B. Prevalence of ras gene mutations in human colorectal cancers. Nature (Lond.), 327: 293-297, 1987.
2. Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., Tuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., White, R., and Vogelstein, B. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (Wash. DC), 244: 217-221, 1989.
3. Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S., Hedge, P., Markham, A., Krush, A. J., Petersen, G., Hamilton, S. R., Nilbert, M. C., Levy, D. B., Bryan, T. M., Preisinger, A. C., Smith, K. J., Su, L. K., Kinzler, K. W., and Vogelstein, B. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (Wash. DC), 253: 665-669, 1991.
4. Zhou, X., Tarmin, L., Yin, J., Jiang, H. Y., Suzuki, H., Rhyu, M. G., Abraham, J. M., and Meltzer, S. J. The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene, 9: 3737-3741, 1994.
5. Toyota, M., Ahuja, N., Suzuki, H., Itoh, F., Ohe-Toyota, M., Imai, K., Baylin, S. B., and Issa, J. P. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res., 59: 5438-5442, 1999.
6. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., and Issa, J. P. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA, 96: 8681-8686, 1999.
7. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci, USA, 93: 9821-9826, 1996.
8. Hibi, K., Taguchi, M., Nakayama, H., Takase, T., Kasai, Y., Ito, K., Akiyama, S., and Nakao, A. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin. Cancer Res., 7: 3135-3138, 2001.
9. Nakayama, H., Hibi, K., Taguchi, M., Takase, T., Yamazaki, T., Kasai, Y., Ito, K., Akiyama, S., and Nakao, A. Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients. Cancer Lett., 188: 115-119, 2002.
10. Ink4a confers susceptibility to metastatic melanoma in mice. Nature (Lond.), 413: 83-86, 2001.
11. Frommer, M., McDonald, L. E., Miller, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., and Paul, C. L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA, 89: 1827-1831, 1992.
12. Clark, S. J., Harrison, J., Paul, C. L., and Frommer, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22: 2990-2997, 1994.
13. Hibi, K., Trink, B., Patturajan, M., Westra, W. H., Caballero, O. L., Hill, D. E., Ratvitski, E. A., Jen, J., and Sidransky, D. AIS is an oncogene amplified in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA, 97: 5462-5467, 2000.
14. Esteller, M., and Herman, J. G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol., 196: 1-7, 2002.
15. Reed, A. L., Califano, J., Cairns, P., Westra, W. H., Jones, R. M., Koch, W., Ahrendt, S., Eby, Y., Sewell, D., Nawroz, H., Bartek, J., and Sidransky, D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56: 3630-3633, 1996.
16. Ahuja, N., Li, Q., Mohan, A. L., Baylin, S. B., and Issa, J-P. J. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res., 58: 5489-5494, 1998.
17. Robertson, K. D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F. A., and Jones, P. A. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res., 27: 2291-2298, 1999.
18. Eads, C. A., Danenberg, K. D., Kawakami, K., Saltz, L. B., Danenberg, P. V., and Laired, P. W. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res., 59: 2302-2306, 1999.
19. Rhee, I., Jair, K-W., Yen, R-W. C., Lengauer, C., Herman, J. G., Kinzler, K. W., Vogelstein, B., Baylin, S. B., and Schuebel, K. E. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature (Lond.), 404: 1003-1007, 2000.